Bar Harbor Wealth Management Has $2.09 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Bar Harbor Wealth Management increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,784 shares of the company’s stock after purchasing an additional 1,648 shares during the period. Bar Harbor Wealth Management’s holdings in GE HealthCare Technologies were worth $2,094,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. LGT Financial Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after acquiring an additional 251 shares in the last quarter. Fred Alger Management LLC bought a new position in shares of GE HealthCare Technologies during the second quarter worth about $26,000. Capital Performance Advisors LLP acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at approximately $26,000. Ashton Thomas Securities LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Finally, Elkhorn Partners Limited Partnership acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at $31,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Activity at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Trading Up 0.7 %

NASDAQ GEHC traded up $0.63 during trading hours on Monday, reaching $85.39. The company’s stock had a trading volume of 1,682,444 shares, compared to its average volume of 3,163,937. The firm has a fifty day simple moving average of $82.25 and a 200-day simple moving average of $84.18. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. GE HealthCare Technologies Inc. has a 52 week low of $71.31 and a 52 week high of $94.55. The stock has a market cap of $39.01 billion, a P/E ratio of 23.46, a P/E/G ratio of 2.90 and a beta of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping analysts’ consensus estimates of $1.06 by $0.08. The company had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. GE HealthCare Technologies’s revenue was up .9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.99 earnings per share. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a $0.035 dividend. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s payout ratio is currently 3.85%.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Stifel Nicolaus increased their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research note on Wednesday, September 18th. Finally, UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and dropped their price objective for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.